Insider transaction details
Oklo Inc. (NASDAQ: OKLO) reported in a Form 4 filing that Chief Financial Officer Richard Craig Bealmear sold 16,342 shares of Class A Common Stock on April 1, 2026. The transaction was executed at $51.08 per share and generated proceeds of $834,749.
The same filing shows Bealmear exercised stock options to acquire shares on two occasions: 16,342 shares were acquired by exercise on April 1, and 5,754 shares were exercised on April 2. The exercises carried an exercise price of $3.18 per share and are reported as having a total exercise cost of $70,265. The sale of 16,342 shares was carried out under a prearranged Rule 10b5-1 trading plan that Bealmear adopted on September 22, 2025.
After these reported transactions, the filing states Bealmear directly owns 386,008 shares of Oklo Inc. Class A Common Stock.
Share-price context and analyst commentary
Oklo's share price has displayed notable volatility: the stock is reported to have declined 62% over the past six months while rising 120% over the past year. The current quoted price of $48.13 is cited in InvestingPro analysis as suggesting potential overvaluation. For investors seeking additional financial detail, the Pro Research Report covering Oklo and more than 1,400 other U.S. equities is available through InvestingPro with further ProTips and analysis.
Corporate developments and strategic partnerships
Oklo recently announced an expansion of its strategic collaboration with Swedish nuclear technology company Blykalla AB. The two companies outlined plans aimed at advancing fast reactor commercialization across the U.S. and Europe. The collaboration description includes contemplated investments and personnel commitments in ranges of $100-200 million and 30-40 engineers, respectively, with the filing noting that these items are subject to final planning and approvals.
Analyst actions and regulatory focus
Within the same period, UBS reduced its price target for Oklo to $60 from $95 while maintaining a Neutral rating, citing execution risks and cost concerns. Craig-Hallum also trimmed its price target to $71 from $87, pointing to the company's capital needs and continuing regulatory processes as considerations influencing its adjustment.
Leadership appointment and industry relevance
Oklo's CEO, Jacob DeWitte, has been named to the President's Council of Advisors on Science and Technology, joining other technology and business leaders on the council. Separately, a report from Bernstein highlighted the role of small modular reactors (SMRs) in meeting the dense, continuous power demands of artificial intelligence workloads and data centers, a trend that aligns with Oklo's technology focus.
What this means
The Form 4 disclosure records both a sale and option exercises by a senior finance executive executed under a 10b5-1 plan, and the company remains active on strategic partnerships and regulatory engagement. Analysts have adjusted price targets downward while noting execution, cost, capital and regulatory risks. These factors together frame the near-term market narrative for Oklo as it pursues commercialization steps for advanced nuclear technologies.